| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Human Placental Lactogen (hPL)
Test Code504X
CPT Codes
83632<br>This test is not available for New York patient testing
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.5 mL
Instructions
Store and ship the specimen frozen.
Red top tube. Allow blood to clot for 30 minutes. Centrifuge at 3000 rpm for 10 minutes. Seperate serum and place in transfer tube. Freeze immediately at -20°C.
Note: Sex and, if pregnant, the gestation period must be included with the requisition.
Red top tube. Allow blood to clot for 30 minutes. Centrifuge at 3000 rpm for 10 minutes. Seperate serum and place in transfer tube. Freeze immediately at -20°C.
Note: Sex and, if pregnant, the gestation period must be included with the requisition.
Transport Temperature
Frozen
Specimen Stability
Room temperature: 4 hours
Refrigerated: 24 hours
Frozen: 90 days
Refrigerated: 24 hours
Frozen: 90 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature • Received refrigerated
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
FDA Status
The performance characteristics of the listed assay was validated by BioAgilytix Diagnostics. The US FDA has not approved or cleared this test. The results of this assay can be used for clinical diagnosis without FDA approval. BioAgilytix Diagnostics is a CLIA certified, CAP accredited laboratory for performing high complexity assays such as this one.
Setup Schedule
A.M. Sets up 1 day a week.
Clinical Significance
Human placental lactogen (hPL; chorionic somatomammotropin) is a 21,000 KD polypeptide produced during pregnancy by placental trophoblastic cells. The level of hPL in maternal serum is directly related to placental function and fetal well-being.
hPL is detected at about 6 weeks after conception and its concentration increases gradually to peak levels (without decreases) until about the 34th week where it remains stable for the remainder of the pregnancy. Consistently low levels throughout pregnancy or a sudden drop in serial determinations are an indication of fetal distress. After normal delivery, the hPL concentration falls rapidly to an undetectable level.
The hPL levels in serum of women with multiple placenta pregnancies generally exceeds that of single placenta pregnancies. This is generally noted from the 2nd trimester to delivery.
hPL is detected at about 6 weeks after conception and its concentration increases gradually to peak levels (without decreases) until about the 34th week where it remains stable for the remainder of the pregnancy. Consistently low levels throughout pregnancy or a sudden drop in serial determinations are an indication of fetal distress. After normal delivery, the hPL concentration falls rapidly to an undetectable level.
The hPL levels in serum of women with multiple placenta pregnancies generally exceeds that of single placenta pregnancies. This is generally noted from the 2nd trimester to delivery.
